Figure 1. Diagram of the study
BC, breast cancer; HBOC, hereditary breast and ovarian cancer; PBL, peripheral blood lymphocytes; CSCE, conformation-sensitive capillary electrophoresis; MLPA, multiplex, ligation-dependent probe amplification; NGS, next generation sequencing; P, pathogenic; LP, likely pathogenic; VUS, variant of unknown significance; ERA, established risk allele.